M&A - Legorreta Pablo G.

Form Type: SCHEDULE 13D

Filing Date: 2025-05-23

Corporate Action: Acquisition

Type: New

Accession Number: 000095010325006385

Filing Summary: On May 16, 2025, Royalty Pharma Holdings Ltd. (RPH), a subsidiary of Royalty Pharma plc, executed a Membership Interests Purchase Agreement to acquire all equity interests of Royalty Pharma Manager, LLC from Sellers including Pablo Legorreta. The transaction provided for the issuance of Class E ordinary shares and Class B Shares to the Sellers, with Legorreta's entity designated to receive over 13 million of each share type. This transaction includes provisions for potential changes in ownership and voting rights, with Legorreta retaining significant influence as CEO and Chairman of the Board.